Researchers explore the effects of a dietary intervention in postpartum women with higher body mass index.
HAEMATO AG (von GBC AG) – Biotech Investments
Original-Research: HAEMATO AG – von GBC AG Einstufung von GBC AG zu HAEMATO AG Unternehmen: HAEMATO AG ISIN: DE000A289VV1 Anlass der Studie: Research study (Anno)